Jie Ding

5.3k total citations
120 papers, 3.9k citations indexed

About

Jie Ding is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jie Ding has authored 120 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 35 papers in Cancer Research and 32 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jie Ding's work include MicroRNA in disease regulation (19 papers), RNA modifications and cancer (15 papers) and Cancer-related molecular mechanisms research (15 papers). Jie Ding is often cited by papers focused on MicroRNA in disease regulation (19 papers), RNA modifications and cancer (15 papers) and Cancer-related molecular mechanisms research (15 papers). Jie Ding collaborates with scholars based in China, United States and South Korea. Jie Ding's co-authors include Xianghuo He, Shenglin Huang, Linhui Liang, Jinjun Li, Yingjun Zhao, Ming Yao, Taoyang Chen, Jianren Gu, Jian Yao and Mingxia Yan and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Jie Ding

113 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jie Ding China 34 2.3k 1.7k 528 506 401 120 3.9k
Guoxiong Xu China 31 1.8k 0.8× 905 0.5× 369 0.7× 561 1.1× 326 0.8× 145 3.5k
Juan Lü China 36 2.7k 1.2× 1.9k 1.1× 516 1.0× 712 1.4× 247 0.6× 143 4.1k
Ning Liu China 38 3.2k 1.4× 2.4k 1.4× 483 0.9× 419 0.8× 192 0.5× 111 4.4k
Yi Zhu China 38 1.9k 0.8× 1.0k 0.6× 334 0.6× 778 1.5× 423 1.1× 144 3.6k
Xianghui Fu China 36 2.4k 1.0× 1.3k 0.8× 474 0.9× 710 1.4× 502 1.3× 103 4.1k
Changjun Yin China 33 1.9k 0.8× 1.1k 0.6× 674 1.3× 402 0.8× 543 1.4× 151 3.4k
Kazuhiro Ikeda Japan 41 3.0k 1.3× 1.3k 0.8× 561 1.1× 721 1.4× 216 0.5× 145 4.8k
Hua Zhong China 22 2.6k 1.1× 2.6k 1.5× 550 1.0× 824 1.6× 326 0.8× 73 5.0k
Ping Yang China 32 1.8k 0.8× 1.4k 0.8× 356 0.7× 492 1.0× 275 0.7× 159 3.3k
Jorge Meléndez-Zajgla Mexico 28 1.5k 0.6× 897 0.5× 299 0.6× 582 1.2× 217 0.5× 123 2.5k

Countries citing papers authored by Jie Ding

Since Specialization
Citations

This map shows the geographic impact of Jie Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Ding more than expected).

Fields of papers citing papers by Jie Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jie Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Ding. The network helps show where Jie Ding may publish in the future.

Co-authorship network of co-authors of Jie Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Jie Ding. A scholar is included among the top collaborators of Jie Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jie Ding. Jie Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Hongquan, Yifei He, Zhen Liu, et al.. (2025). CRISPR screening reveals that RNA helicase DDX41 triggers ribosome biogenesis and cancer progression through R-loop-mediated RPL/RPS transcription. Nature Communications. 16(1). 7409–7409. 1 indexed citations
2.
3.
Zhao, Yuhang, Tommaso Cai, Cheng Fu, et al.. (2025). Liquid vs. solid: The superior choice of material in intracranial tumors preoperative embolization — A systematic review and meta-analysis. Neurosurgical Review. 48(1). 704–704.
4.
Dong, Keqin, Jie Ding, Jia Xia, et al.. (2024). CRISPR genome-wide screening identifies PAK1 as a critical driver of ARSI cross-resistance in prostate cancer progression. Cancer Letters. 587. 216725–216725. 8 indexed citations
5.
Shangguan, Xun, et al.. (2022). Squalene Epoxidase Metabolic Dependency Is a Targetable Vulnerability in Castration-Resistant Prostate Cancer. Cancer Research. 82(17). 3032–3044. 30 indexed citations
6.
Luo, Jia, Shaojun Chen, Bowen Shi, et al.. (2022). Non-drug efflux function of ABCC5 promotes enzalutamide resistance in castration-resistant prostate cancer via upregulation of P65/AR-V7. Cell Death Discovery. 8(1). 241–241. 8 indexed citations
7.
Shi, Qili, Jie Ding, Xinrong Li, et al.. (2022). RNA binding protein RALY activates the cholesterol synthesis pathway through an MTA1 splicing switch in hepatocellular carcinoma. Cancer Letters. 538. 215711–215711. 20 indexed citations
8.
Ding, Jie, et al.. (2022). MicroRNA-mediated reprogramming of glucose, fatty acid and amino acid metabolism in cancer. 4(2). 47–69. 4 indexed citations
9.
Ding, Jie, Yan Chen, Yun Mou, et al.. (2020). Overexpression of FNTB and the activation of Ras induce hypertrophy and promote apoptosis and autophagic cell death in cardiomyocytes. Journal of Cellular and Molecular Medicine. 24(16). 8998–9011. 13 indexed citations
10.
Ding, Jie, Xu Zhang, Chuangqi Chen, et al.. (2020). Ultra pH-sensitive polymeric nanovesicles co-deliver doxorubicin and navitoclax for synergetic therapy of endometrial carcinoma. Biomaterials Science. 8(8). 2264–2273. 21 indexed citations
11.
Duan, Yiyuan, Honghao Zheng, Zehua Li, et al.. (2020). Unsaturated polyurethane films grafted with enantiomeric polylysine promotes macrophage polarization to a M2 phenotype through PI3K/Akt1/mTOR axis. Biomaterials. 246. 120012–120012. 77 indexed citations
12.
13.
Li, Zhe, Jiwei Zhang, Xinyang Liu, et al.. (2018). The LINC01138 drives malignancies via activating arginine methyltransferase 5 in hepatocellular carcinoma. Nature Communications. 9(1). 1572–1572. 170 indexed citations
14.
Lu, Xinyuan, Di Chen, Jie Ding, et al.. (2018). Predicting Value of ALCAM as a Target Gene of microRNA-483-5p in Patients with Early Recurrence in Hepatocellular Carcinoma. Frontiers in Pharmacology. 8. 973–973. 25 indexed citations
15.
Chou, Fu-Ju, Keliang Wang, Rachel Yang, et al.. (2017). Androgen receptor (AR) degradation enhancer ASC-J9 ® in an FDA-approved formulated solution suppresses castration resistant prostate cancer cell growth. Cancer Letters. 417. 182–191. 38 indexed citations
16.
Chen, Zhiao, Zhijun Wang, Weijie Guo, et al.. (2014). TRIM35 Interacts with pyruvate kinase isoform M2 to suppress the Warburg effect and tumorigenicity in hepatocellular carcinoma. Oncogene. 34(30). 3946–3956. 73 indexed citations
17.
Waldron, Levi, Benjamin Haibe‐Kains, Aedín C. Culhane, et al.. (2014). Comparative Meta-analysis of Prognostic Gene Signatures for Late-Stage Ovarian Cancer. JNCI Journal of the National Cancer Institute. 106(5). 87 indexed citations
18.
Zhai, Kan, et al.. (2014). HPV and lung cancer risk: A meta-analysis. Journal of Clinical Virology. 63. 84–90. 49 indexed citations
19.
Lin, Jun, Shenglin Huang, Shun‐Quan Wu, et al.. (2011). MicroRNA-423 promotes cell growth and regulates G 1 /S transition by targeting p21Cip1/Waf1 in hepatocellular carcinoma. Carcinogenesis. 32(11). 1641–1647. 104 indexed citations
20.
Guan, Na, Songming Huang, Dongfeng Zhang, et al.. (2010). [Risk factors of melamine-contaminated milk powder related urolithiasis: a multicenter nested case-control study].. PubMed. 42(6). 690–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guoxiong Xu Breakdown of academic impact, for papers by Juan Lü Breakdown of academic impact, for papers by Ning Liu Breakdown of academic impact, for papers by Yi Zhu Breakdown of academic impact, for papers by Xianghui Fu Breakdown of academic impact, for papers by Changjun Yin Breakdown of academic impact, for papers by Kazuhiro Ikeda Breakdown of academic impact, for papers by Hua Zhong Breakdown of academic impact, for papers by Ping Yang Breakdown of academic impact, for papers by Jorge Meléndez-Zajgla
Rankless by CCL
2026